Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction.
Sebastian Johannes ReinstadlerThomas StiermaierCharlotte EitelBernhard MetzlerSuzanne de WahaGeorg FuernauSteffen DeschHolger ThieleIngo EitelPublished in: Diabetes, obesity & metabolism (2017)
Diabetic patients with STEMI, especially those having ITDM, had an increased risk of MACE. The adverse clinical outcome was, however, not explained by an impact of DM on reperfusion success or myocardial damage. Clinical trial registry number: NCT00712101.
Keyphrases
- st elevation myocardial infarction
- clinical trial
- type diabetes
- percutaneous coronary intervention
- glycemic control
- acute myocardial infarction
- cerebral ischemia
- cardiovascular disease
- left ventricular
- st segment elevation myocardial infarction
- oxidative stress
- phase ii
- acute coronary syndrome
- wound healing
- coronary artery disease
- open label
- acute ischemic stroke
- double blind
- study protocol
- phase iii
- insulin resistance
- brain injury
- heart failure
- emergency department
- atrial fibrillation
- weight loss